Health & Science Technologies - Higher volumes in data center power, semiconductor, space, and defense markets, along with positive pricing, drove organic sales growth in this segment.
Price/cost benefit & tariff refunds - Gross margin and adjusted gross margin rose due to net productivity improvements, volume leverage, and positive price/cost, with IEEPA tariff refunds contributing 150 basis points to both measures.
Order growth - Record orders of over $1 bln, up 29% on a reported basis, reflected elevated demand in key markets where the company has focused investments.
Q2 results beat estimates
Engineered products maker's Q2 sales rose 6%, beating analyst expectations.
Adjusted diluted EPS for Q2 increased 12%, also beating analyst expectations.
IEX•
